Satraplatin for Patients With Metastatic Breast Cancer (MBC)

Clinical trial NCT00265655 · COMPLETED

Trial details

NCT number: NCT00265655
Sponsor: Agennix
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2005-11-01
Primary completion: 2008-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.